Location: Home
  • search
  • go
  • Relate News
  • 10/2/2024China Introduces Credit System for Hospital and Pharmacy Staff to Curb...
  • 10/2/2024China Issues New Regulation on Network Data Security Management
  • 10/2/2024CDE Solicits Comments on the Proposed Technical Guidelines for Writing...
  • 10/2/2024CDE Solicits Comments on the Proposed BE Study Guidelines for Five Gen...
  • 10/2/2024CDE Solicits Comments on the Proposed Technical Guidelines for Clinica...
  • 10/2/2024CDE Solicits Comments on the Proposed Technical Guidelines for Clinica...
  • 10/2/2024Publication Announcement on the Inclusion of Marstacimab as Pilot Proj...
  • 10/1/2024Asieris Pharma Reports Positive Phase III Results for Cervical HSIL Tr...
  • 10/1/2024Kailera Secures $400M Series A Funding to Develop Obesity and Diabetes...
  • 10/1/2024HUTCHMED Announces Japan Approval for FRUZAQLA (fruquintinib) Received...
  • 10/1/2024NH Reports MAT H1/2024 Data on the Chinese Cough, Cold and Allergy Mar...
  • 10/1/2024InventisBio Prevails in Trade Secret Misappropriation Lawsuit Filed by...
  • 10/1/2024Alphamab and CSPC Enter a Licensing Deal on Anti-HER2 BsADC JSKN003 in...
  • 10/1/2024Genentech to Acquire Regor Pharma’ Next-Generation CDK Inhibitor Port...
  • 10/1/2024Akeso's Ebronucimab (PCSK9) Approved for Hypercholesterolemia in China
  • 10/1/2024NMPA Conditionally Approves Qilu's QL1706 (Iparomlimab + Tuvonralimab)...
  • 10/1/2024AstraZeneca's Seeks Chinese Approval of Antisense Therapy Eplontersen ...
  • 10/1/2024Biotheus to Initiate Phase 3 Trial of BsAb PM8002 for SCLC
  • 10/1/2024Regeneron and Sanofi Announced Chinese Approval of Dupixent as the Fir...
  • 10/1/2024MediLink Registers Phase 3 Trial of Its B7H3 ADC YL201
  • 10/1/2024Lepu Biopharma Files NDA for Lead Product EGFR ADC MRG003
  • 10/1/2024Akeso's Cadonilimab Receives Second Indication Approval from NMPA
  • 10/1/2024LEO Pharma Submits NDA for Enstilar for Adults with Plaque Psoriasis i...
  • 10/1/2024Haleon Plans to Raise Stake in Chinese JV to 88%
  • 10/1/2024AFT in China License Deal with Xizang Weixinkang Pharma for Maxigesic ...
  • 10/1/2024China and US to Renew Health Cooperation Following Washington Talks
  • 10/1/2024China's Pharmaceutical Antimonopoly Guidelines Pose New Challenges for...
  • 9/27/2024Pharma Companies in Beijing Free Trade Zone to Benefit from Relaxed Da...
  • 9/27/2024Daehwa Pharm's Liporaxel Gains Chinese Approval to Treat Gastric Cance...
  • 9/27/2024China Rises as a Major Player in Oncology with ADCs Boom: GlobalData
  • Page:59/786 Total number of articles:23558: [First][<<] [57] [58] [59] [60] [61] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group